Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway

Aerobic glycolysis is a well‐known hallmark of hepatocellular carcinoma (HCC). Hence, targeting the key enzymes of this pathway is considered a novel approach to HCC treatment. The effects of sodium butyrate (NaBu), a sodium salt of the short‐chain fatty acid butyrate, on aerobic glycolysis in HCC c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qiang, Dai, Weiqi, Ji, Jie, Wu, Liwei, Feng, Jiao, Li, Jingjing, Zheng, Yuanyuan, Li, Yan, Cheng, Ziqi, Zhang, Jie, Wu, Jianye, Xu, Xuanfu, Guo, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097842/
https://www.ncbi.nlm.nih.gov/pubmed/35429101
http://dx.doi.org/10.1111/jcmm.17322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097842/
https://www.ncbi.nlm.nih.gov/pubmed/35429101
http://dx.doi.org/10.1111/jcmm.17322

Ejemplares similares